NEPHRODI

NephroDI Therapeutics is a pharmaceutical company focusing on concentration disorders of the kidney. NephroDI is initially developing an oral drug to treat Nephrogenic Diabetes Insipidus (NDI) in children, a pediatric orphan disease... NephroDI Therapeutics is developing a novel AMPK activator as a first-in-class potential therapy for Nephrogenic Diabetes Insipidus (NDI).

Also known as: NephroDI Therapeutics, NephroDI Therapeutics, Inc.